GENMAB

Genmab A/S

Application Filed: 2006-12-14

Trademark Application Details

Status

706

Live/Registered

SECTION 71 ACCEPTED

Research	OneLook Acronym Finder
Serial Number	79040923
Registration Number	3431559
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Mark Lerner
Attorney Name	Mark Lerner Esq.
Attorney Docket Number	101983-0016
Law Office Assigned	M70
Employee Name	MORRIS, KRISTINA KLOIB

Timeline

2006-12-14	Application Filed
2008-03-04	Published for Opposition
2008-05-20	Trademark Registered
2018-11-19	Location: GENERIC WEB UPDATE
2018-11-19	Status: Live/Registered
2018-11-19	Transaction Date

Trademark Applicants & Owners

Owner:	Genmab A/S
Address	Kalvebod Brygge 43 DK-1560 Copenhagen V DK
Legal Entity Type
Legal Entity State	DK

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Mark Lerner Esq.
Satterlee Stephens LLP
230 Park Avenue, Suite 1130
NEW YORK, NY 10169

Good, Services, and Codes

International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0421	Medical scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies

Type Code

Type

GS0421

Medical scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis; patent exploitation, namely, patent licensing; licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	2007-08-16	1 SDRC M:
LIMITATION OF GOODS/SERVICES FROM IB ENTERED	2007-08-20	2 LIMS I:Incoming Correspondence
NEW APPLICATION ENTERED IN TRAM	2007-08-21	3 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2007-08-21	4 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2007-08-25	5 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2007-08-26	6 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2007-08-27	7 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2007-08-27	8 RFCS P:
REFUSAL PROCESSED BY IB	2007-09-14	9 RFNT P:
PAPER RECEIVED	2007-11-28	10 MAIL I:Incoming Correspondence
ASSIGNED TO LIE	2008-01-10	11 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE	2008-01-10	12 CRFA I:Incoming Correspondence
AMENDMENT FROM APPLICANT ENTERED	2008-01-10	13 ACEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2008-01-28	14 CNSA O:Outgoing Correspondence
LAW OFFICE PUBLICATION REVIEW COMPLETED	2008-01-30	15 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2008-02-13	16 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2008-03-04	17 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2008-05-20	18 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2008-08-21	19 FICR P:
FINAL DISPOSITION PROCESSED	2008-09-10	20 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB	2008-09-10	21 FICS P:
CHANGE OF NAME/ADDRESS REC'D FROM IB	2010-07-15	22 ADCH M:
INTERNATIONAL REGISTRATION RENEWED	2011-03-04	23 RNWL P:
NEW REPRESENTATIVE AT IB RECEIVED	2011-11-11	24 NREP P:
FINAL DECISION TRANSACTION PROCESSED BY IB	2012-12-29	25 FINO P:
TEAS SECTION 71 RECEIVED	2014-05-15	26 ES71 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2014-06-02	27 APRE A:Allowance for Publication
REGISTERED-SEC.71 FILED	2014-05-15	28 71AF I:Incoming Correspondence
REGISTERED-SEC.71 ACCEPTED	2014-06-03	29 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2014-06-04	30 NA71 E:E-Mail
CHANGE OF NAME/ADDRESS REC'D FROM IB	2017-02-09	31 ADCH M:
NEW REPRESENTATIVE AT IB RECEIVED	2017-02-09	32 NREP P:
NEW REPRESENTATIVE AT IB RECEIVED	2017-04-20	33 NREP P:
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	2017-05-20	34 REM4 E:E-Mail
NEW REPRESENTATIVE AT IB RECEIVED	2017-09-08	35 NREP P:
CHANGE OF NAME/ADDRESS REC'D FROM IB	2017-10-26	36 ADCH M:
TEAS SECTION 71 RECEIVED	2018-11-14	37 ES71 I:Incoming Correspondence
REGISTERED-SEC.71 ACCEPTED	2018-11-19	38 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2018-11-19	39 NA71 E:E-Mail
INTERNATIONAL REGISTRATION RENEWED	2021-02-25	40 RNWL P:
CHANGE OF NAME/ADDRESS REC'D FROM IB	2023-09-15	41 ADCH M:

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
GENMAB 79040923 3431559 Live/Registered	Genmab A/S 2006-12-14
GENMAB 76105834 2850023 Live/Registered	Genmab A/S 2000-08-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.